QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.22%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.22%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.22%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.22%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
Log in
NASDAQ:ABEO

Abeona Therapeutics News Headlines

$2.01
-0.07 (-3.37 %)
(As of 03/5/2021 05:28 PM ET)
Add
Compare
Today's Range
$1.70
Now: $2.01
$2.14
50-Day Range
$1.79
MA: $2.36
$3.39
52-Week Range
$0.99
Now: $2.01
$3.79
Volume3.92 million shs
Average Volume5.24 million shs
Market Capitalization$198.04 million
P/E RatioN/A
Dividend YieldN/A
Beta1.69

Headlines

Abeona Therapeutics (NASDAQ ABEO) News Headlines Today

Source:
SourceHeadline
Abeona Therapeutics (NASDAQ:ABEO) Downgraded to "Sell" at Zacks Investment ResearchAbeona Therapeutics (NASDAQ:ABEO) Downgraded to "Sell" at Zacks Investment Research
marketbeat.com - February 19 at 3:49 PM
Abeona Therapeutics (NASDAQ:ABEO) Trading Down 7.2%Abeona Therapeutics (NASDAQ:ABEO) Trading Down 7.2%
americanbankingnews.com - March 3 at 8:24 PM
Consultant on Cambridge gene therapy firm acquisition pleads guilty to insider tradingConsultant on Cambridge gene therapy firm acquisition pleads guilty to insider trading
bizjournals.com - March 3 at 2:54 PM
Former CEO who became biotech consultant pleads guilty to insider tradingFormer CEO who became biotech consultant pleads guilty to insider trading
reuters.com - March 2 at 5:54 PM
Abeona Therapeutics (NASDAQ:ABEO) Trading Up 13.2%Abeona Therapeutics (NASDAQ:ABEO) Trading Up 13.2%
americanbankingnews.com - February 25 at 7:18 PM
Billionaire Ken Griffin Pulls the Trigger on These 2 Penny StocksBillionaire Ken Griffin Pulls the Trigger on These 2 Penny Stocks
finance.yahoo.com - February 25 at 1:19 PM
Independent Director Paul Mann Just Sold A Bunch Of Shares In Abeona Therapeutics Inc. (NASDAQ:ABEO)Independent Director Paul Mann Just Sold A Bunch Of Shares In Abeona Therapeutics Inc. (NASDAQ:ABEO)
nasdaq.com - February 22 at 7:36 AM
Abeona Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare ConferenceAbeona Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
finance.yahoo.com - February 22 at 7:36 AM
Todd Wider Sells 321,345 Shares of Abeona Therapeutics Inc (NASDAQ:ABEO) StockTodd Wider Sells 321,345 Shares of Abeona Therapeutics Inc (NASDAQ:ABEO) Stock
americanbankingnews.com - February 19 at 9:06 PM
Abeona Therapeutics (NASDAQ:ABEO) Trading Down 6.5%Abeona Therapeutics (NASDAQ:ABEO) Trading Down 6.5%
americanbankingnews.com - February 18 at 8:12 PM
Abeona Therapeutics (NASDAQ:ABEO) Given Outperform Rating at SVB LeerinkAbeona Therapeutics (NASDAQ:ABEO) Given Outperform Rating at SVB Leerink
americanbankingnews.com - February 18 at 6:52 AM
HC Wainwright Reiterates "Buy" Rating for Abeona Therapeutics (NASDAQ:ABEO)HC Wainwright Reiterates "Buy" Rating for Abeona Therapeutics (NASDAQ:ABEO)
americanbankingnews.com - February 16 at 8:23 AM
Head-To-Head Review: Lannett (NYSE:LCI) versus Abeona Therapeutics (NASDAQ:ABEO)Head-To-Head Review: Lannett (NYSE:LCI) versus Abeona Therapeutics (NASDAQ:ABEO)
americanbankingnews.com - February 14 at 10:21 AM
Abeona Therapeutics Inc (NASDAQ:ABEO) Short Interest Up 69.4% in JanuaryAbeona Therapeutics Inc (NASDAQ:ABEO) Short Interest Up 69.4% in January
americanbankingnews.com - February 14 at 2:28 AM
Abeona Therapeutics (NASDAQ:ABEO) Stock Price Down 11.9%Abeona Therapeutics (NASDAQ:ABEO) Stock Price Down 11.9%
americanbankingnews.com - February 12 at 8:18 PM
New Positive Phase 1/2 Interim Data Presented at WORLDSymposium™ Shows Neurocognitive Development of Young MPS IIIA Patients Preserved up to Three Years Following Treatment with Abeona’s ABO-102 Gene TherapyNew Positive Phase 1/2 Interim Data Presented at WORLDSymposium™ Shows Neurocognitive Development of Young MPS IIIA Patients Preserved up to Three Years Following Treatment with Abeona’s ABO-102 Gene Therapy
finance.yahoo.com - February 12 at 1:40 PM
Abeona Therapeutics Inc (NASDAQ:ABEO) Director Sells $722,400.00 in StockAbeona Therapeutics Inc (NASDAQ:ABEO) Director Sells $722,400.00 in Stock
americanbankingnews.com - February 11 at 12:30 AM
Stock Traders Purchase High Volume of Call Options on Abeona Therapeutics (NASDAQ:ABEO)Stock Traders Purchase High Volume of Call Options on Abeona Therapeutics (NASDAQ:ABEO)
americanbankingnews.com - February 9 at 12:34 PM
Abeona Therapeutics (NASDAQ:ABEO) Shares Gap Up to $3.39Abeona Therapeutics (NASDAQ:ABEO) Shares Gap Up to $3.39
americanbankingnews.com - February 9 at 11:06 AM
Consultant to Cambridge gene therapy firm charged with insider tradingConsultant to Cambridge gene therapy firm charged with insider trading
bizjournals.com - February 5 at 6:43 PM
Abeona Therapeutics Announces Clinical Investigator Webinar to Review ABO-102 and ABO-101 Clinical Data Presented at the 17th Annual WORLDSymposium™Abeona Therapeutics Announces Clinical Investigator Webinar to Review ABO-102 and ABO-101 Clinical Data Presented at the 17th Annual WORLDSymposium™
finance.yahoo.com - February 2 at 9:50 AM
Abeona Therapeutics Announces Successful Type B Meeting with FDA for Pivotal Phase 3 VIITAL™ Study of EB-101 in Recessive Dystrophic Epidermolysis Bullosa (RDEB)Abeona Therapeutics Announces Successful Type B Meeting with FDA for Pivotal Phase 3 VIITAL™ Study of EB-101 in Recessive Dystrophic Epidermolysis Bullosa (RDEB)
finance.yahoo.com - January 25 at 8:29 AM
Epidermolysis bullosa pipeline anticipated to offer several novel pipeline therapies in the next decadeEpidermolysis bullosa pipeline anticipated to offer several novel pipeline therapies in the next decade
benzinga.com - January 13 at 4:02 PM
Do Options Traders Know Something About Abeona (ABEO) Stock We Dont?Do Options Traders Know Something About Abeona (ABEO) Stock We Don't?
finance.yahoo.com - January 12 at 1:15 PM
Batten Disease Treatment Market May See a Big Move : Major Giants Celenex, Pfizer, BioMarin PharmaceuticalBatten Disease Treatment Market May See a Big Move : Major Giants Celenex, Pfizer, BioMarin Pharmaceutical
marketwatch.com - December 29 at 11:59 PM
Genetic Modification Therapies Market Research 2020-2025: Market Analysis, Drivers, Restraints, Opportunities, and ThreatsGenetic Modification Therapies Market Research 2020-2025: Market Analysis, Drivers, Restraints, Opportunities, and Threats
marketwatch.com - December 16 at 2:55 PM
Is ABEO A Good Stock To Buy Now?Is ABEO A Good Stock To Buy Now?
finance.yahoo.com - December 14 at 10:31 PM
Biogen (BIIB) & Sage Therapeutics Partner for Depression TherapiesBiogen (BIIB) & Sage Therapeutics Partner for Depression Therapies
nasdaq.com - November 30 at 4:46 PM
How Much Are Abeona Therapeutics Inc. (NASDAQ:ABEO) Insiders Spending On Buying Shares?How Much Are Abeona Therapeutics Inc. (NASDAQ:ABEO) Insiders Spending On Buying Shares?
finance.yahoo.com - November 12 at 9:18 AM
Why This Abeona Therapeutics Analyst Is Turning Bullish After Q3 PrintWhy This Abeona Therapeutics Analyst Is Turning Bullish After Q3 Print
msn.com - November 11 at 2:24 PM
Abeona Therapeutics (ABEO) Reports Q3 LossAbeona Therapeutics (ABEO) Reports Q3 Loss
finance.yahoo.com - November 9 at 11:05 PM
Abeona Therapeutics EPS beats by $0.06, beats on revenueAbeona Therapeutics EPS beats by $0.06, beats on revenue
seekingalpha.com - November 9 at 6:05 PM
Abeona Therapeutics Reports Third Quarter Financial ResultsAbeona Therapeutics Reports Third Quarter Financial Results
finance.yahoo.com - November 9 at 6:05 PM
Abeona Therapeutics Announces the Appointment of Michael Amoroso as Chief Operating OfficerAbeona Therapeutics Announces the Appointment of Michael Amoroso as Chief Operating Officer
finance.yahoo.com - October 27 at 7:53 AM
Abeona Therapeutics IncAbeona Therapeutics Inc
bloomberg.com - October 16 at 12:03 AM
Abeona Therapeutics’ Board of Directors Forms Special Committee to Oversee Operations, Develop Strategic Direction and Leadership PlanAbeona Therapeutics’ Board of Directors Forms Special Committee to Oversee Operations, Develop Strategic Direction and Leadership Plan
nasdaq.com - October 7 at 1:47 AM
Why Abeonas Stock Is Trading Lower TodayWhy Abeona's Stock Is Trading Lower Today
benzinga.com - September 28 at 9:50 PM
Abeona Therapeutics announces leadership transitionAbeona Therapeutics announces leadership transition
seekingalpha.com - September 28 at 11:49 AM
Why Abeona Therapeutics Is Trading Higher TodayWhy Abeona Therapeutics Is Trading Higher Today
finance.yahoo.com - September 18 at 5:56 PM
Abeona Therapeutics rallies on B.Rileys Buy ratingAbeona Therapeutics rallies on B.Riley's Buy rating
seekingalpha.com - September 18 at 12:56 PM
Abeona Therapeutics to Participate in Upcoming Investor ConferencesAbeona Therapeutics to Participate in Upcoming Investor Conferences
finance.yahoo.com - September 8 at 7:31 PM
Are Institutions Heavily Invested In Abeona Therapeutics Inc.s (NASDAQ:ABEO) Shares?Are Institutions Heavily Invested In Abeona Therapeutics Inc.'s (NASDAQ:ABEO) Shares?
finance.yahoo.com - September 1 at 8:34 AM
Are Institutions Heavily Invested In Abeona Therapeutics Inc.'s (NASDAQ:ABEO) Shares?Are Institutions Heavily Invested In Abeona Therapeutics Inc.'s (NASDAQ:ABEO) Shares?
finance.yahoo.com - September 1 at 8:34 AM
BUZZ-U.S. STOCKS ON THE MOVE-Washington Prime, Abeona Therapeutics, Principia BiopharmaBUZZ-U.S. STOCKS ON THE MOVE-Washington Prime, Abeona Therapeutics, Principia Biopharma
nasdaq.com - August 17 at 1:47 PM
Abeona Therapeutics inks deal for ABO-202 with Taysha Gene TherapiesAbeona Therapeutics inks deal for ABO-202 with Taysha Gene Therapies
seekingalpha.com - August 17 at 8:46 AM
Abeona Therapeutics and Taysha Gene Therapies Enter into Licensing and Inventory Purchase Agreements for ABO-202, a Clinical Stage, Novel, One-time Gene Therapy for CLN1 DiseaseAbeona Therapeutics and Taysha Gene Therapies Enter into Licensing and Inventory Purchase Agreements for ABO-202, a Clinical Stage, Novel, One-time Gene Therapy for CLN1 Disease
finance.yahoo.com - August 17 at 8:46 AM
Abeona Therapeutics EPS beats by $0.03Abeona Therapeutics EPS beats by $0.03
seekingalpha.com - August 10 at 5:47 PM
Abeona Therapeutics Inc.: Abeona Therapeutics Reports Second Quarter Financial Results and Business UpdatesAbeona Therapeutics Inc.: Abeona Therapeutics Reports Second Quarter Financial Results and Business Updates
finanznachrichten.de - August 10 at 5:47 PM
Abeona Therapeutics Reports Second Quarter Financial Results and Business UpdatesAbeona Therapeutics Reports Second Quarter Financial Results and Business Updates
finance.yahoo.com - August 10 at 5:47 PM
Did Hedge Funds Make The Right Call On Abeona Therapeutics Inc (ABEO)Did Hedge Funds Make The Right Call On Abeona Therapeutics Inc (ABEO)
finance.yahoo.com - August 4 at 3:16 PM
Forge Biologics Launches with $40 Million Series A Financing to Manufacture and Develop Gene TherapiesForge Biologics Launches with $40 Million Series A Financing to Manufacture and Develop Gene Therapies
www.businesswire.com - July 21 at 8:41 AM
This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.